Company
GoldmanSachs International
TIDM
TTP
Headline
EMM Disclosure
Released
12:19 29 Jan 2003
Number
7701G
RNS Number:7701G
GoldmanSachs International
29 January 2003
EMM DISCLOSURE
FORM 38.5 (SUMMARY)
Lodge with a RIS and the Takeover Panel. Use a separate form for each
class of securities in which dealings have been made.
CONNECTED EXEMPT MARKET- MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Name of EMM
Goldman Sachs International
Date of disclosure
29 January 2003
Contact name
Peter Highton
Telephone number
+44 207-774-1935
Please see attached disclosure of dealings under Rule 38.5 in the
securities of the following companies:
Oxford Glycosciences plc
Cambridge Antibody Technology Group plc
AMENDMENT
If the attached Rule 38.5 disclosure is to amend a previous disclosure,
please state which element(s) of previous disclosure was incorrect:
In the case of option business or dealings in derivatives full details
should be given on a separate sheet so that the nature of the dealings
can be fully understood. For options this should include the number of
securities under option, the exercise period (or in the case of exercise,
the exercise date), the exercise price and any option money paid or
received. For derivatives this should include, at least, the number of
reference securities to which they relate (when relevant), the maturity
date (or if applicable the closing out date) and the reference price.
For full details of the disclosure requirements see Rules 8 and 38 of
the Code. If in doubt contact the Monitoring Section of the Panel, Tel.
No: 020 7638 0129. Email: monitoring@disclosure.org.uk
FORM 38.5
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in (name of company)
Oxford Glycosciences plc
Class of security
Ordinary Shares
Date of disclosure
29 January 2003
Date of dealing
28 January 2003
Name of EMM
Goldman Sachs International
Name of offeree/offeror with whom connected
Oxford Glycosciences plc
Total number of securities purchased
0
Highest price paid*
0.00 GBP Sterling
Lowest price paid*
0.00 GBP Sterling
Total number of securities sold
5,682
Highest price received*
1.75 GBP Sterling
Lowest price received*
1.75 GBP Sterling
*Currency must be stated
FORM 38.5
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in (name of company)
Cambridge Antibody Technology Group plc
Class of security
Ordinary Shares
Date of disclosure
29 January 2003
Date of dealing
28 January 2003
Name of EMM
Goldman Sachs International
Name of offeree/offeror with whom connected
Oxford Glycosciences plc
Total number of securities purchased
15,955
Highest price paid*
4.8366 GBP Sterling
Lowest price paid*
4.8366 GBP Sterling
Total number of securities sold
0
Highest price received*
0.00 GBP Sterling
Lowest price received*
0.00 GBP Sterling
*Currency must be stated